Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Financial Collapse of 2001 Unwinding -- Ignore unavailable to you. Want to Upgrade?

To: elmatador who wrote (4865)	3/19/2020 7:47:41 AM
From: Dr. Voodoo	Read Replies (3) \| Respond to of 13803

for serious patients, especially those in 80's not much can do, Italy has a lot of serious patients. After ventilator, and full blown immune response--really need anti-inflammatory and treatment alternatives. IL-6 antibody scale up to blockbuster size is not fish in a barrel. Need small molecule drugs. Team France and MSM have shat on ibuprofen, but not acetaminophen etc. Have so many patients, they must try drug regimens for those who have nothing left to lose.. I am hopeful for US less serious,,, testing and diagnosis early can lead way for better care and more SK outcome Am convinced prophylactic drug therapy even if 50% effective is 75-95% effective at flattening the curve. No way to test except on selves. Am not convinced systemic architecture has planned for 100 X blockbuster demand, officialdoms much be convinced, contingency liabilities, paperwork, ramp up, who gets what and when... all problematic for drugs on horizon. Right now we are in the weeds, I think this will turn bigly before fall.